Stockreport

ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer

Erytech Pharma S.A. - American Depositary Shares  (ERYP) 
US:NASDAQ Investor Relations: investors.erytech.com
PDF More than 75% of the planned ~500 patients enrolled in the trialTrial to continue as planned after third safety review by independent data monitoring committeeInterim su [Read more]